Clinical Trial Update: Tirofiban and Enoxaparin in High Risk Coronary Intervention [Phase 4]

View source ↗

Summary

Phase 4 trial update evaluating tirofiban and enoxaparin in high-risk coronary intervention for acute coronary syndrome; the study status is completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Syndrome

Drugs mentioned

• Aggrastat (tirofiban)
• Lovenox (enoxaparin)

Snippet

Sponsor: The Prince Charles Hospital | Conditions: Acute Coronary Syndrome | Phase 4 | Status: COMPLETED